Clearwater Practice Outlines Non-Surgical Submental Fat Reduction Options
Clearwater, United States – February 18, 2026 / Lux Injectables /
CLEARWATER, Fla. – February 17, 2026 – Lux Injectables has released educational information detailing the use of Kybella, an FDA-approved injectable treatment indicated for reducing moderate to severe submental fat beneath the chin.
Submental fullness, commonly referred to as a double chin, can persist despite weight management and regular exercise. According to the U.S. Food and Drug Administration, Kybella is approved for the treatment of fat beneath the chin and works by destroying fat cells in the targeted area.
Kybella contains synthetic deoxycholic acid, a molecule naturally produced by the body to help absorb dietary fat. When injected into submental fat, the solution disrupts fat cell membranes. The body then gradually clears the treated cells through natural metabolic processes over several weeks.
“Kybella offers a non-surgical option for patients who have fullness under the chin caused by fat rather than skin laxity or structural concerns,” the practice stated. “A thorough consultation is necessary to determine candidacy.”
Candidates typically include individuals with moderate to severe submental fullness who maintain good skin elasticity and prefer to avoid surgical procedures such as liposuction or neck lift surgery. Individuals who are pregnant, have active infections in the treatment area, or have certain anatomical concerns may require alternative evaluation.
Each treatment session generally lasts 20 to 30 minutes and involves a series of small injections mapped carefully beneath the chin. Providers may use topical numbing agents or cooling techniques to enhance comfort. Swelling, firmness, and tenderness commonly occur after treatment and are considered expected responses as the medication begins its action.
Most individuals require a series of sessions spaced approximately four to six weeks apart. The total number of treatments depends on the amount of fat present, individual response, and desired contour outcomes. Clinical guidance indicates that once fat cells are destroyed, they do not regenerate, though maintaining a stable weight remains important for long-term results.
Common side effects include swelling, bruising, numbness, and localized tenderness. Less common but more serious complications may include temporary nerve irritation or difficulty swallowing. The FDA advises that treatment should be administered by qualified medical professionals familiar with facial anatomy to reduce risk.
Kybella differs from other aesthetic approaches. Liposuction is a surgical procedure requiring anesthesia and recovery time. Neck lift surgery addresses excess skin rather than fat. Dermal fillers and neurotoxins target structural contouring and muscle movement but do not eliminate fat cells. Treatment selection depends on clinical evaluation.
Lux Injectables noted that individualized assessment remains central to determining appropriate intervention. Providers evaluate skin elasticity, fat distribution, and overall facial balance before recommending treatment.
Additional information regarding consultation scheduling and treatment eligibility is available at https://luxinjectables.com/contact/
About Lux Injectables
Lux Injectables is a Clearwater-based aesthetic practice led by Jessica Manges, ARNP. The practice provides non-surgical cosmetic treatments focused on evidence-based protocols and individualized patient assessment.
Contact Information:
Lux Injectables
1831 N Belcher Rd. Suite C-1
Clearwater, FL 33765
United States
Jessica Manges
(727) 698-8225
https://luxinjectables.com/
